Angiogenex Inc AGGX:OTC Pink - No Information (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 0.135 | 0.00 0.00% | 2,500 | 750 |
Latest News Headlines for Angiogenex Inc
Company Background
AngioGenex, Inc. (AngioGenex) is a development-stage company. The Company is a biopharmaceutical company focused on the manufacturing of products for the treatment, diagnosis and prognosis of cancer. The Company focuses to develop orally active anti-cancer drugs that act by modulating the action of the inhibitor of differentiation (Id) proteins, measurement of Id proteins in tumors and blood to create products for the diagnosis and prognosis of cancer and generating proof-of-concept data in relevant preclinical models to establish that modulation of Id genes and proteins is useful to treat non-oncologic diseases in which a surplus or deficit in the growth of blood vessels is an important part of the underlying pathology.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 0.135 |
| Previous Close | 0.135 |
| Day High | -- |
| Day Low | -- |
| 52 Week High | 7/14/2014 | 0.40 |
| 52 Week Low | 10/25/2013 | 0.0015 |
| % Off 52 Week High | (66.25)% |
| % Off 52 Week Low | 8,900.00% |
| Beta (5 Yr) | -- |
| Volatility Avg | 10/8/2014 | -- |
| 10-Day Avg. Volume | 750 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 9/30/2009 | (0.02) |
|---|---|
| P/E Ratio | 9/30/2009 | -- |
| Market Cap | Micro Cap | 3M |
| Shares Outstanding | 21.30M |
| Float | 16.5M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpAGGX Angiogenex Inc vs. Peers
| Peers | |
|---|---|
AGGX Angiogenex Inc | 237.50% |
Pfizer Inc. | -4.08% |
Merck & Co., Inc. | 20.24% |
Bristol Myers Squibb Co. | -5.53% |
Eli Lilly & Co. | 27.92% |
AGGX Angiogenex Inc | 0.00% |
Pfizer Inc. | 3.54% |
Merck & Co., Inc. | 2.92% |
Bristol Myers Squibb Co. | 2.87% |
Eli Lilly & Co. | 3.00% |
AGGX Angiogenex Inc | 0.00% |
Pfizer Inc. | 2.05% |
Merck & Co., Inc. | 2.94% |
Bristol Myers Squibb Co. | 0.88% |
Eli Lilly & Co. | 1.59% |